Abstract
Recent in vitro and in vivo experiments have revealed that ellagic acid and its metabolites can inhibit the growth of digestive system malignant tumor cells by inhibiting tumor cell proliferation, inducing apoptosis, breaking DNA binding to carcinogens, blocking virus infection, disturbing inflammation, angiogenesis and drug-resistance processes required for tumor metastasis. Ellagic acid and its metabolites are potential chemoprevention and therapeutic drugs against human cancers. Key words: Ellagic acid; Digestive system neoplasms; Chemoprevention; Molecular mechanisms of pharmacological action
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
